Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure

BACKGROUND: Hyperbaric oxygen therapy (HBOT) has been proposed to address COVID-19- associated respiratory failure. However, its biochemical effects are poorly known. METHOD: 50 patients with hypoxemic COVID-19 pneumonia were divided into C group (standard care) and H group (standard care plus HBOT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Guillermo A., Colaianni, Ivana, Coria, Javier, Di Girolamo, Guillermo, Miranda, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927797/
https://www.ncbi.nlm.nih.gov/pubmed/36796547
http://dx.doi.org/10.1016/j.rmed.2023.107155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927797/
https://www.ncbi.nlm.nih.gov/pubmed/36796547
http://dx.doi.org/10.1016/j.rmed.2023.107155

Ejemplares similares